Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 13, 2018

SELL
$32.09 - $34.78 $89,242 - $96,723
-2,781 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $80,537 - $94,554
2,781
2,781 $94,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $214B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Bank Of Nova Scotia Trust CO Portfolio

Follow Bank Of Nova Scotia Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia Trust CO with notifications on news.